MRCM
BNTX icon

M&R Capital Management’s BioNTech BNTX Stock Holding History

M&R Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$33.6K Buy
283
+63
+29% +$5.79K 0.01% 268
2024
Q2 		$17.7K Buy
220
+200
+1,000% +$18.3K ﹤0.01% 307
2024
Q1 		$1.84K Buy
+20
New +$1.92K ﹤0.01% 500

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M&R Capital Management's BNTX Position: Q3 2024 in Review

M&R Capital Management increased its BioNTech (BNTX) stake by 29% in Q3 2024, buying an estimated $5.79K and bringing the position to 283 shares worth $33.6K. The position accounts for 0.01% of the portfolio, ranked #268.

M&R Capital Management first reported a position in BNTX in Q1 2024 and has held it in 3 quarters since. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • M&R Capital Management held 283 shares of BioNTech worth $33.6K as of Q3 2024.
  • M&R Capital Management bought 63 BioNTech shares in Q3 2024, an estimated $5.79K.
  • BioNTech made up 0.01% of M&R Capital Management's portfolio in Q3 2024, its #268 holding.
  • M&R Capital Management first reported a position in BioNTech in Q1 2024 and has held it in 3 quarters since.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.